Autor: |
Carme Font, Juan Esteban Gomez-Mesa, Juan Jose López-Núñez, Caterina Calderón, Stephania Galindo-Coral, Carol C. Wu, Junsheng Ma, Michael H. Kroll, Cristhiam Mauricio Rojas-Hernandez |
Rok vydání: |
2022 |
DOI: |
10.21203/rs.3.rs-1693582/v1 |
Popis: |
Purpose Therapy for cancer associated-venous thromboembolism (VTE) includes long term anticoagulation, which may have substantial impact on the health-related quality of life (HRQL) of patients. We assessed patient-reported outcomes to characterize the HRQL associated with VTE treatment and to begin to examine those HRQL elements impacting anticoagulation adherence (AA). Methods Participants were adult cancer patients with confirmed symptomatic acute lower extremity deep venous thrombosis. Patients were excluded if there was an indication for anticoagulation other than VTE, ECOG performance status > 3 or life expectancy |
Databáze: |
OpenAIRE |
Externí odkaz: |
|